| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/11/2011 | EP2319826A1 Succinate salt of O-desmethyl-venlafaxin |
| 05/11/2011 | EP2319585A1 Pharmaceutical products and compositions comprising salmeterol, fluticasone and ipratropium or tiotropium |
| 05/11/2011 | EP2319584A1 Pharmaceutical products and compositions comprising salmeterol, ciclesonide and tiotropium |
| 05/11/2011 | EP2319583A1 Pharmaceutical products and compositions comprising salmeterol, budesonide and ipratropium |
| 05/11/2011 | EP2319582A1 Pharmaceutical products and compositions comprising formoterol, budesonide and tiotropium or oxitropium |
| 05/11/2011 | EP2319558A2 Mems device for delivery of therapeutic agents |
| 05/11/2011 | EP2319519A1 Composition for inhibiting expression of target gene |
| 05/11/2011 | EP2319515A1 Coccidicide combination for veterinary use |
| 05/11/2011 | EP2319514A1 Stable aqueous solution composition containing sulfonamide compound |
| 05/11/2011 | EP2319513A1 Nicotinic acid compositons for treating hyperlipidemia and related methods therefor |
| 05/11/2011 | EP2319510A1 Benzoyl peroxide composition for treating skin |
| 05/11/2011 | EP2319505A1 Transdermal dosage form comprising an active agent component and an adverse agent component in a ratio from 1:10 up to 10:1 |
| 05/11/2011 | EP2319504A1 Pharmaceutical solid dosage form |
| 05/11/2011 | EP2319503A2 Drug delivery carrier |
| 05/11/2011 | EP2319502A1 Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 05/11/2011 | EP2319501A1 Pharmaceutical formulations for carrier-mediated transport statins and uses thereof |
| 05/11/2011 | EP2319500A1 Rapid acting drug delivery compositions |
| 05/11/2011 | EP2319499A1 Alcohol resistant dosage forms |
| 05/11/2011 | EP2319498A1 Taste-masked multiparticulate pharmaceutical composition comprising a drug-containing core particle and a solvent-coacervated membrane |
| 05/11/2011 | EP2319497A1 Stable shaped particles of crystalline organic compounds |
| 05/11/2011 | EP2319496A1 Pharmaceutical preparation containing oxycodone and naloxone |
| 05/11/2011 | EP2319495A2 Membrane scaffold proteins |
| 05/11/2011 | EP2319494A1 Pharmaceutical compositions for the treatment of asthma |
| 05/11/2011 | EP2319493A2 Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/11/2011 | EP2319492A2 Method for treating intraocular neovascular diseases |
| 05/11/2011 | EP2318366A2 Psma-binding agents and uses thereof |
| 05/11/2011 | EP2318350A1 ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 muM TO ABOUT 10 muM |
| 05/11/2011 | EP2318191A2 Method of manufacturing cellular films directly |
| 05/11/2011 | EP2318052A1 Nanocrystal nano-emulsion |
| 05/11/2011 | EP2318051A2 In vitro diagnostic markers comprising carbon nanoparticles and kits |
| 05/11/2011 | EP2318001A1 Modified release formulation and methods of use |
| 05/11/2011 | EP2317993A2 Methods of administering topical antifungal formulations for the treatment of fungal infections |
| 05/11/2011 | EP2317990A2 Microparticulate oral drug form useful for the modified release of nanoparticles |
| 05/11/2011 | EP2317989A2 Microparticles |
| 05/11/2011 | EP2317988A1 Pharmaceutical dosage forms for time-specific drug delivery |
| 05/11/2011 | EP2317987A1 Eprosartan compositions |
| 05/11/2011 | EP2317986A2 System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract |
| 05/11/2011 | EP2317985A2 Modified release ramipril compositions and uses thereof |
| 05/11/2011 | EP2317984A1 Articles of manufacture releasing an active ingredient |
| 05/11/2011 | EP2317983A1 Pharmaceutical formulation comprising a cb1-receptor compound in a solid solution and/or solid dispersion |
| 05/11/2011 | EP2317982A2 Methods of processing compositions containing microparticles |
| 05/11/2011 | EP2317981A1 Multi-layered lamellar granule and skin external application composition containing same |
| 05/11/2011 | EP2317980A2 Pharmaceutical compositions of rivaroxaban with modified release properties |
| 05/11/2011 | EP2317979A2 Pharmaceutical compositions of somatotrophic hormones |
| 05/11/2011 | EP2317978A2 Stable injectable oil-in-water docetaxel nanoemulsion |
| 05/11/2011 | EP2317977A2 Pharmaceutical composition having relatively low ionic strength |
| 05/11/2011 | EP2317976A1 Methods and ophtalmic devices used in the treatment of ocular allergies |
| 05/11/2011 | EP2317975A1 Octreotide implant having a release agent |
| 05/11/2011 | EP2317974A2 Appetising medicaments for oral administration in solid form for prevention and/or treatment of cardiac insufficiency in animals |
| 05/11/2011 | EP2317973A2 Appetising medicament for oral administration in solid form |
| 05/11/2011 | EP2317869A1 Production of beadlets comprising hygroscopic plant extracts |
| 05/11/2011 | EP2101742B1 Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form |
| 05/11/2011 | EP1900368B1 Tablet containing hardly soluble active ingredient |
| 05/11/2011 | EP1866148B1 Multi-ply technical composite which is breathable and moisturising, releases active constituents and promotes their absorption, and can be used as a medical aid or to make clothing or structures that come into direct contact with healthy or diseased skin |
| 05/11/2011 | EP1672025B1 Finely particulate composite containing carbon compound encapsulated therein |
| 05/11/2011 | EP1458360B1 Pulmonary delivery of aminoglycosides |
| 05/11/2011 | EP1453916B1 Combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 05/11/2011 | EP1405621B1 Method of manufacturing tablet |
| 05/11/2011 | EP1161227B1 Microparticles for delivery of nucleic acid |
| 05/11/2011 | EP1061803B1 Compositions of eprosartan |
| 05/11/2011 | EP0885002B1 Materials and methods for enhancing cellular internalization |
| 05/11/2011 | EP0876109B2 Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use |
| 05/11/2011 | CN201823086U Folium artemisiae argyi paste |
| 05/11/2011 | CN201823085U Paster for treating superficial phlebitis |
| 05/11/2011 | CN1943664B The Chinese traditional medicinal cream for treatment of eczema |
| 05/11/2011 | CN1917883B Use of treprostinil in preparing medicine to improve kidney functions |
| 05/11/2011 | CN1899614B Preparation for the prophylaxis of restenosis |
| 05/11/2011 | CN1899439B Chinese medicine composition for treating goat and its use |
| 05/11/2011 | CN1895237B Officinal magnolia phenol lipid frozen dried powder preparation and its use in preparing drug for cancers |
| 05/11/2011 | CN1876152B A medicine for treating nervous deafness and preparation process thereof |
| 05/11/2011 | CN1854148B Astragalus total heteroside extract and its production |
| 05/11/2011 | CN1813812B Liquid capsule for treating diseases caused by pathogenic wind hot and its preparing method |
| 05/11/2011 | CN1658823B Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 05/11/2011 | CN102056622A Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| 05/11/2011 | CN102056611A Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications |
| 05/11/2011 | CN102056610A Fine granules having improved suspension performance in water |
| 05/11/2011 | CN102056599A Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 05/11/2011 | CN102056598A Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative |
| 05/11/2011 | CN102056597A Gingival wafer |
| 05/11/2011 | CN102056596A Nanoparticle formulations and uses thereof |
| 05/11/2011 | CN102056595A Biodegradable impact-modified polymer compositions |
| 05/11/2011 | CN102056594A Pharmaceutical depot comprising N-{5-[(cyclopropylamino)carbonyl]-2-methylphenyl}-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 05/11/2011 | CN102056593A Nasal formulations of insulin |
| 05/11/2011 | CN102056592A Stable crystal modifications of DOPC |
| 05/11/2011 | CN102056590A Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 05/11/2011 | CN102056589A Solid pharmaceutical formulations comprising BIBW 2992 |
| 05/11/2011 | CN102049090A Moxibustion patch and preparation method thereof |
| 05/11/2011 | CN102049051A Medicinal composition for stabilizing pholcodine granules |
| 05/11/2011 | CN102049045A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 05/11/2011 | CN102049042A Novel oral compound capsule preparation for treating diabetes and obesity |
| 05/11/2011 | CN102049033A Medicament for intervention treatment of chronic obstructive pulmonary disease and preparation method thereof |
| 05/11/2011 | CN102049032A Oral liquid capable of strengthening spleen, replenishing qi and nourishing blood and preparation method thereof |
| 05/11/2011 | CN102049029A Chinese medical preparation for treating infantile diarrhea |
| 05/11/2011 | CN102049028A Method for establishing HPLC (high performance liquid chromatography) fingerprint graphic for ointment for unblocking collaterals and relieving pain as well as standard fingerprint graphic thereof |
| 05/11/2011 | CN102049018A Preparation method of ointment for treating sprain |
| 05/11/2011 | CN102049011A Chinese herbal medicine pill capable of invigorating brain and nourishing heart |
| 05/11/2011 | CN102049008A Traditional Chinese medicine composition for treating chloasma and preparation method thereof |
| 05/11/2011 | CN102049007A Medical anti-inflammatory and anti-toxic external cream and preparation method thereof |
| 05/11/2011 | CN102049000A Bulbus fritillariae cirrhosae oral liquid and preparation method thereof |
| 05/11/2011 | CN102048998A Medicine prepared by taking termites as main raw material and used for treating hepatitis B |